Neogen Corporation

    Jurisdiction
    United States
    LEI
    549300HJT9FC36N4UW43
    ISIN
    US6404911066 (NEOG)
    Sectors
    1. Healthcare
    2. Medical - Diagnostics & Research

    Scores

    InsiderPie Expert Score
    trending_flat 48 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    4 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    1 / 7

    Profile

    Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €767.62M
    Gross margin
    47.1%
    EBIT
    -€910.34M
    EBIT margin
    -118.6%
    Net income
    -€936.97M
    Net margin
    -122.1%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €709.31M -7.6% N/A
    €722.10M +1.8% -€22.62M
    €737.60M +2.1% -€16.22M -28.3%

    Dividends

    No dividend payouts

    Products

    Product Revenue
    Product €797.32M 103.9%
    Service €97.35M 12.7%

    Earnings Calls

    Latest earnings call: April 9, 2024

    Investor transactions

    Name Shares Value Last change Change type
    James Anderson 9.2M $79.41M -590K Sell

    Add to watchlist

    Notifications